Tag: Tetrabenazine

VMAT2 inhibitors function by depleting monoamine neurotransmitters like dopamine in the brain, thereby controlling involuntary movements. This class of drugs, including tetrabenazine, deutetrabenazine, and valbenazine, is used to manage specific movement disorders like tardive dyskinesia and Huntington's chorea.

Affecting one in four patients taking certain antipsychotic medications, tardive dyskinesia is a significant movement disorder [1.8.3]. So, **what type of drug is deutetrabenazine?** It is a vesicular monoamine transporter 2 (VMAT2) inhibitor used to manage this and other movement disorders [1.2.1].

Over 18 million men in the United States over age 20 are affected by erectile dysfunction. While this leads many to research medications, it's crucial to correctly identify any pill. So, **what is a yellow pill with T 2 on it?** The answer isn't straightforward, as this marking is used on several different drugs.

An estimated 70% of patients taking antipsychotic medication experience dopamine-related side effects, such as hyperprolactinemia. So, **what medication depletes dopamine** and what are the specific mechanisms involved? These medications range from psychiatric drugs to those that treat severe movement disorders, with different approaches to reducing dopamine's influence in the brain.

First approved by the FDA in 2008 as the first drug specifically for a symptom of Huntington's disease, tetrabenazine was a landmark treatment. So, what does tetrabenazine treat, and how does it manage the involuntary movements associated with certain neurological conditions?